The Gross Margin of Eiger BioPharmaceuticals Inc (EIGR) is 99.90%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2022-12-31 | 99.90% |
2021-12-31 | 93.90% |